CD8A and brain neoplasm: To address this possibility, WT CD45.1 CD8+ T cells and CD45.2 CXCR6 KO T cells were activated for 24 hours before being injected at a 1:1 ratio into RAG-1KO mice harboring CT-2A brain tumors (Figure 4C).